Profil
Janice Lu is currently the Chief Medical Officer at Ambrx Biopharma Cayman, Inc. She previously worked as an Associate Professor-Clinical Medicine at the University of California, Los Angeles and as a Clinical Professor-Medicine at USC Norris Comprehensive Cancer Center.
She holds a doctorate degree from Peking University and Syracuse University.
Aktive Positionen von Janice Lu
| Unternehmen | Position | Beginn |
|---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Technik-/Wissenschafts-/F&E-Leiter | 17.05.2022 |
Ehemalige bekannte Positionen von Janice Lu
| Unternehmen | Position | Ende |
|---|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
USC Norris Comprehensive Cancer Center
USC Norris Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Operates a cancer hospital | Corporate Officer/Principal | - |
Ausbildung von Janice Lu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Norris Comprehensive Cancer Center
USC Norris Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Operates a cancer hospital | Health Services |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syracuse University
Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
















